Gyros Protein Technologies, provider of automated nanoliter-scale immunoassays, peptide synthesisers and reagents, has appointed of Mark Vossenaar as Vice President Sales, Europe.
Vossenaar brings more than 25 years of experience in developing and leading life and health science commercial teams, having worked for large and small companies such as Amersham Bioscience, GE Healthcare, Stratagene, Agilent Technologies and most recently, Hill-Rom International.
Established in March 2016 by the merger of Gyros and Protein Technologies, Gyros Protein Technologies combines Gyros’ microfluidics, systems development and immunoassay expertise with Protein Technologies’ knowledge in developing and manufacturing instruments for peptide synthesis.
The company provides customers a range of peptide synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing.
